COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,628 Articles (22,913 medRxiv, 8,715 bioRxiv)

Most recent first Previous |  Page 859: Articles 8581-8590  | Next

Predictors and barriers for the management of non-communicable diseases among older Syrian refugees amidst the COVID-19 pandemic in Lebanon: A cross-sectional analysis of a multi-wave survey
McCall, S. J., El Khoury, T., Salibi, N., Abi Zeid, B., El Haddad, M., Alawieh, M. F., Abdulrahim, S., Chaaya, M., Ghattas, H., Sibai, A. M.
10.1101/2022.04.12.22273786 — Posted: 2022-04-17
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations
Carreno Quiroz, J. M., Singh, G., Tcheou, J., Srivastava, K., Gleason, C., Muramatsu, H., Desai, P., Aberg, J. A., Miller, R. L., PARIS study group, , Pardi, N., Simon, V., Krammer, F.
10.1101/2022.04.15.22273914 — Posted: 2022-04-17
Safety and effectiveness of RBD-specific polyclonal equine F(ab')2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: a retrospective cohort study.
Farizano Salazar, D. H., Achinelli, F., Colonna, M., Perez, L., Gimenez, A. A., Ojeda, M. A., Miranda Puente, S. N., Sanchez Negrete, L., Canete, F., Martelotte Ibarra, O. I., Sanguineti, S., Spatz, L., Goldbaum, F. A., Massa, C., Rivas, M., Pichel, M., Hiriart, Y., Zylberman, V., Gallego, S., Konigheim, B., Fernandez, F., Deprati, M., Roubicek, I., Giunta, D. H., Nannini, E., Lopardo, G., Belloso, W. H.
10.1101/2022.04.07.22273558 — Posted: 2022-04-17
Evaluation of isotype specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults
Thomas, A. C., Oliver, E., Baum, H., Gupter, K., Shelley, K., Long, A., Jones, H., Smith, J., Hitchings, B., di Bartolo, N., Vasileiou, K., Rabi, F., Alamir, H., Eghleilib, M., Francis, O., Oliver, J., Morales-Aza, B., Obst, U., Shattock, D., Barr, R., Collingwood, L., Duale, K., Grace, N., Gonnage Livera, G., Bishop, L., Downing, H., Rodrigues, F., Timpson, N. J., Relton, C. J., Toye, A. M., Woolfson, D. N., Berger, I., Goenka, A., Davidson, A. D. M., Gillespie, K. M., Williams, A. J., Bailey, M., Brooks-Pollock, E., Finn, A., Halliday, A., CoMMinS Study Team
10.1101/2022.04.11.22273690 — Posted: 2022-04-17
Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers -- Mexico, March-December 2021
Richardson, V. L., Camacho Franco, M. A., Bautista Marquez, A., Martinez Valdez, L., Castro Ceronio, L. E., Cruz Cruz, V., Gharpure, R., Lafond, K. E., Yau, T. S., Azziz-Baumgartner, E., Hernandez Avila, M.
10.1101/2022.04.14.22273413 — Posted: 2022-04-17
Coronavirus infection in neonates: Neurodevelopmental outcomes at 18 months of age
Ayed, M., Alsaffar, Z., Bahzad, Z., Buhamad, Y., Abdulkareem, A., AlQattan, A., Embaireeg, A., Kartam, M., Alkandari, H.
10.1101/2022.04.15.22273460 — Posted: 2022-04-17
Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (CovishieldTM) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021
Murali, S., Sakthivel, M., P, K., Venkataswamy, V., Thangaraj, J. W. V., Shete, A., John, A., Arjun, J., C P, G. K., Yadav, P. D., Sahay, R., Majumdar, T., Dhudhmal, M., Sivalingam, A., D, S. R., D, A., R, V., M, M. M., A, S., M, P., G, E., C, P., S, D. P. V., M, P., P, E., Parasuraman, G., M, J., Narnaware, M. S., Bedi, G. S., Kaur, P., Murekhar, M. V.
10.1101/2022.04.15.22273859 — Posted: 2022-04-16
Can We Really Trust the Findings of the COVID-19 Research? Quality Assessment of Randomized Controlled Trials Published on COVID-19
Joshy, A. S., Thomas, C., Surendran, S., Undela, K.
10.1101/2022.04.15.22273881 — Posted: 2022-04-16
Introduction and Establishment of SARS-CoV-2 Gamma Variant in New York City in Early 2021
Vasylyeva, T. I., Fang, C. E., Su, M., Havens, J. L., Parker, E., Wang, J. C., Zeller, M., Yakovleva, A., Hassler, G. W., Chowdhury, M. A., Andersen, K. G., Hughes, S., Wertheim, J. O.
10.1101/2022.04.15.22273909 — Posted: 2022-04-16
Using a real-world network to model the tradeoff between stay-at-home restriction, vaccination, social distancing and working hours on COVID-19 dynamics.
Nashebi, R., Sari, M., Kotil, S.
10.1101/2022.04.15.22273449 — Posted: 2022-04-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).